Soleus Capital Management »

Adagio Therapeutics shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $19M 7.7M 2.47

More positions owned by Soleus Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Krystal Biotech (KRYS)
Celcuity (CELC)
Novocure Ord Shs (NVCR)
Praxis Precision Medicines I Com New (PRAX)
Tg Therapeutics (TGTX)
Dex (DXCM)
BioMarin Pharmaceutical (BMRN)
Globus Med Cl A (GMED)
Beta Bionics (BBNX)
Amicus Therapeutics (FOLD)
Twist Bioscience Corp (TWST)
Organogenesis Hldgs (ORGO)
Syndax Pharmaceuticals (SNDX)
Mirum Pharmaceuticals (MIRM)

View all positions for Soleus Capital Management

Top funds holding Adagio Therapeutics

Henderson Group
Maverick Capital
RA Capital Management
Point72 Asset Management
Mithril II GP
Vanguard Group
Driehaus Capital Management
M28 Capital Management
Soleus Capital Management
Eventide Asset Management
State Street Corporation
ADAR1 Capital Management
683 Capital Management
Ikarian Capital
Redmile Group

View all funds holding Adagio Therapeutics